Gulf Pharmaceutical Industries PSC (JULPHAR):企業の財務・戦略的SWOT分析

◆英語タイトル:Gulf Pharmaceutical Industries PSC (JULPHAR) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0999
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:UAE
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Gulf Pharmaceutical Industries PSC (JULPHAR) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Gulf Pharmaceutical Industries PSC (Julphar) is a pharmaceutical company that manufactures and distributes medicines in the Middle East and North Africa region. The company’s product portfolio consists of antibiotics, antiseptics, wound care and biotechnology, women care, adult primary care, pediatric primary care, cardiopulmonary care, gastro care and pain management and consumer care products. The company has manufacturing facilities in Ethiopia, Bangladesh and Saudi Arabia. Julphar has offices in Asia, Middle East and Africa and is headquartered in Digdaga, Ras Al Khaimah, the UAE.

Gulf Pharmaceutical Industries PSC Key Recent Developments

Nov 14,2019: Julphar reports financial results for Q3 2019
Oct 13,2019: Julphar appoints new Chief Finance & Strategy Officer
Jun 21,2019: Julphar bolsters management team with new senior appointments
Apr 18,2019: Julphar’s Chairman and Vice-Chairman step down
Apr 04,2019: Julphar to support Zimbabwe healthcare sector

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Gulf Pharmaceutical Industries PSC – Key Facts
Gulf Pharmaceutical Industries PSC – Key Employees
Gulf Pharmaceutical Industries PSC – Key Employee Biographies
Gulf Pharmaceutical Industries PSC – Major Products and Services
Gulf Pharmaceutical Industries PSC – History
Gulf Pharmaceutical Industries PSC – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Gulf Pharmaceutical Industries PSC – Business Description
Gulf Pharmaceutical Industries PSC – SWOT Analysis
SWOT Analysis – Overview
Gulf Pharmaceutical Industries PSC – Strengths
Gulf Pharmaceutical Industries PSC – Weaknesses
Gulf Pharmaceutical Industries PSC – Opportunities
Gulf Pharmaceutical Industries PSC – Threats
Gulf Pharmaceutical Industries PSC – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Gulf Pharmaceutical Industries PSC, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 14, 2019: Julphar reports financial results for Q3 2019
Oct 13, 2019: Julphar appoints new Chief Finance & Strategy Officer
Jun 21, 2019: Julphar bolsters management team with new senior appointments
Apr 18, 2019: Julphar’s Chairman and Vice-Chairman step down
Apr 04, 2019: Julphar to support Zimbabwe healthcare sector
Feb 15, 2019: Julphar announces 2018 preliminary results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Gulf Pharmaceutical Industries PSC, Key Facts
Gulf Pharmaceutical Industries PSC, Key Employees
Gulf Pharmaceutical Industries PSC, Key Employee Biographies
Gulf Pharmaceutical Industries PSC, Major Products and Services
Gulf Pharmaceutical Industries PSC, History
Gulf Pharmaceutical Industries PSC, Subsidiaries
Gulf Pharmaceutical Industries PSC, Joint Venture
Gulf Pharmaceutical Industries PSC, Key Competitors
Gulf Pharmaceutical Industries PSC, Ratios based on current share price
Gulf Pharmaceutical Industries PSC, Annual Ratios
Gulf Pharmaceutical Industries PSC, Annual Ratios (Cont...1)
Gulf Pharmaceutical Industries PSC, Annual Ratios (Cont...2)
Gulf Pharmaceutical Industries PSC, Interim Ratios
Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Gulf Pharmaceutical Industries PSC, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Gulf Pharmaceutical Industries PSC, Performance Chart (2014 - 2018)
Gulf Pharmaceutical Industries PSC, Ratio Charts
Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Gulf Pharmaceutical Industries PSC (JULPHAR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • KPJ Healthcare Berhad (KPJ):企業の財務・戦略的SWOT分析
    Summary KPJ Healthcare Berhad (KPJ) is a healthcare service provider that offers medical services. The center offers services in the areas of anaesthesiology, cardiology and cardiothoracic surgery, child psychiatry, clinic pathology, occupational health services, orthopaedic and trauma surgery, diet …
  • CVR Energy, Inc.:企業の戦略・SWOT・財務情報
    CVR Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary CVR Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Grid2020 Inc:企業の戦略的SWOT分析
    Grid2020 Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • CellaVision AB (CEVI):企業の財務・戦略的SWOT分析
    CellaVision AB (CEVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bend Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary Bend Research Inc (Bend Research), a subsidiary of Capsugel Inc is a provider of drug delivery technologies and formulation development services. The company offers services such as formulation science, dosage form development, process development, engineering, cGMP manufacturing, bioprocess …
  • LVMH Moet Hennessy Louis Vuitton SA:戦略・SWOT・企業財務分析
    LVMH Moet Hennessy Louis Vuitton SA - Strategy, SWOT and Corporate Finance Report Summary LVMH Moet Hennessy Louis Vuitton SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Seventh Sense Biosystems Inc-医療機器分野:企業M&A・提携分析
    Summary Seventh Sense Biosystems Inc (Seventh Sense) is a medical device company that develops and markets blood collection devices. The company’s products comprise testing devices, TAP devices, sterile and microneedle arrays among others. It uses TAP Touch Activated Phlebotomy painless blood collec …
  • Taiflex Scientific Co Ltd (8039):企業の財務・戦略的SWOT分析
    Taiflex Scientific Co Ltd (8039) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Vozrozhdenie Bank (VZRZ):企業の財務・戦略的SWOT分析
    Summary Vozrozhdenie Bank (VB) is a banking service provider that provides corporate business, retail business, bank cards transactions and financial market operations. The company provides personal banking and business services. It products include debit and credit cards, accounts, and others. VB o …
  • Spine Injury Solutions Inc (SPIN):企業の財務・戦略的SWOT分析
    Summary Spine Injury Solutions Inc (SPIN), formerly Spine Pain Management Inc is a medical service provider that provides medical technology and healthcare management solutions for liability spine injuries. The company provides services such as clinical management, and billing and collection of medi …
  • Vonovia SE:企業の戦略・SWOT・財務分析
    Vonovia SE - Strategy, SWOT and Corporate Finance Report Summary Vonovia SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • 10X Genomics, Inc.:製薬・医療:M&Aディール及び事業提携情報
    Summary 10X Genomics, Inc. (10X Genomics) is engaged in developing an innovative genomics platform. The company’s product pipeline comprises of chromium controller, single cell ATAC sequencer and single cell with barcode technology. It offers single cell gene expression, single cell immune profiling …
  • Neptune Technology Group Inc:企業の戦略的SWOT分析
    Neptune Technology Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Eidgenossische Technische Hochschule Zurich-医療機器分野:企業M&A・提携分析
    Summary Eidgenossische Technische Hochschule Zurich(ETH Zurich) is an educational university that offers studies in technology and the natural sciences. The university provides scientific education through bachelor programmes and master programmes in the areas of applied geophysics, architecture, bi …
  • Sacgasco Ltd (SGC):企業の財務・戦略的SWOT分析
    Summary Sacgasco Ltd (Sacgasco) formerly Australian Oil Company Ltd, is an energy company that provides conventional oil and gas exploration, development and production across Australia. The company develops and produces clean natural gas in the Sacramento Basin, onshore California. It explores Sacr …
  • QBE Insurance Group Limited:企業のM&A・事業提携・投資動向
    QBE Insurance Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's QBE Insurance Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • PellePharm Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PellePharm Inc (PellePharm), a subsidiary of BridgeBio Inc, is a biotechnology company that develops and commercializes treatments for rare genetic dermatological conditions. The company’s lead clinical program, Patidegib, is a first-in-class topical gel formulation of a proprietary hedgehog …
  • PacificHealth Laboratories Inc-製薬・医療分野:企業M&A・提携分析
    Summary PacificHealth Laboratories Inc (PacificHealth) is a healthcare products provider that develops and commercializes patented nutrition products. The company's products comprise endurox r4, accelerade, accelerade hydro, accel gel, endurox excel, 2nd surge and accel recover. Its dietary and nutr …
  • MicuRx Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MicuRx Pharmaceuticals Inc (MicuRx) is a developer of antibiotics for drug-resistant bacterial infections. The company develops a pipeline of antimicrobial agents using its proprietary drug discovery platform to treat both gram-positive and gram-negative bacterial infections. It offers produ …
  • YTL Power International Berhad (YTLPOWR):企業の財務・戦略的SWOT分析
    YTL Power International Berhad (YTLPOWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆